Patch vs. pill: new study aims to stop chemo sickness in transplant patients
NCT ID NCT04150614
First seen Nov 12, 2025 · Last updated May 13, 2026 · Updated 25 times
Summary
This study tests whether a skin patch (granisetron) works better than a standard oral drug (ondansetron) to prevent nausea and vomiting in people getting chemotherapy before a stem cell transplant. About 90 adults aged 18-75 will take part. Both groups also receive dexamethasone. The goal is to see which approach helps more patients avoid vomiting and the need for extra rescue medicines in the first 24 hours after chemo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAUSEA WITH VOMITING CHEMOTHERAPY-INDUCED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Illinois Cancer Center
RECRUITINGChicago, Illinois, 60612, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.